Ethic Inc’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,281
Closed -$265K 1078
2023
Q2
$265K Sell
6,281
-640
-9% -$25.9K 0.01% 825
2023
Q1
$247K Buy
+6,921
New +$251K 0.01% 840
2022
Q3
Sell
-3,130
Closed -$224K 851
2022
Q2
$224K Sell
3,130
-1,389
-31% -$102K 0.02% 691
2022
Q1
$366K Buy
4,519
+1,510
+50% +$128K 0.03% 544
2021
Q4
$309K Buy
3,009
+610
+25% +$58.6K 0.02% 522
2021
Q3
$210K Sell
2,399
-118
-5% -$10.7K 0.02% 572
2021
Q2
$225K Buy
+2,517
New +$213K 0.03% 514

Other funds holding SYNH

Ethic Inc's SYNH Position: Q3 2023 in Review

Ethic Inc sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 6,281 shares — an estimated $265K sold.

Ethic Inc first reported a position in SYNH in Q2 2021 and held it in 7 quarters. The position peaked at $366K in Q1 2022. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Ethic Inc reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Ethic Inc sold 6,281 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $265K.
  • Ethic Inc first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2021 and held it in 7 quarters.
  • Ethic Inc's Syneos Health, Inc. Class A Common Stock position peaked at $366K in Q1 2022.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Ethic Inc's 13F filing for Q3 2023, filed 14 Nov 2023.